Drug search by name

Olumiant and Laboratory abnormalities

Result of checking the interaction of drug Olumiant and disease Laboratory abnormalities for safety when used together.

Check result:

Olumiant <> Laboratory abnormalities

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Treatment with baricitinib was associated with an increased incidence of neutropenia, decrease lymphocyte counts and in hemoglobin levels. Therapy initiation is not recommended in patients with an absolute lymphocyte count (ALC) less than 500 cells/mm3, absolute neutrophil count (ANC) less than 1000 cells/mm3, or hemoglobin level less than 8 g/dL. Evaluate at baseline and thereafter according to routine patient management and modified dose accordingly. Exercise caution in patients who may be at increased risk.

Olumiant

Generic Name: baricitinib

Brand Name: Olumiant

Synonyms: n.a.

What is Olumiant?